Skip to content
healthcare.dev

URIMAR-T CAPS

NDC 28595-224, methenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, and hyoscyamine sulfate, capsule, from Allegis Pharmaceuticals, LLC.

Product NDC
28595-224
Status
Listed
Labeler
Allegis Pharmaceuticals, LLC
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
UNAPPROVED DRUG OTHER
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/28595-224 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METHENAMINE120 mg/1
  • SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE40.8 mg/1
  • PHENYL SALICYLATE36.2 mg/1
  • METHYLENE BLUE10.8 mg/1
  • HYOSCYAMINE SULFATE.12 mg/1

Pharmacologic classes

Oxidation-Reduction Activity [MoA]; Oxidation-Reduction Agent [EPC]

Package NDCNDC-11Package
28595-224-602859502246060 CAPSULE in 1 BOTTLE (28595-224-60)

Linked data

RxNorm, label and prices

Use it

Look up 28595-224 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/28595-224 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 28595-224. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.